Astrotech (NASDAQ:ASTC) Upgraded at Wall Street Zen

by · The Markets Daily

Wall Street Zen upgraded shares of Astrotech (NASDAQ:ASTC – Free Report) from a strong sell rating to a sell rating in a report published on Saturday.

Separately, Weiss Ratings upgraded Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, May 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Check Out Our Latest Stock Report on ASTC

Astrotech Trading Up 3.7%

Shares of NASDAQ:ASTC opened at $6.78 on Friday. Astrotech has a 12 month low of $1.91 and a 12 month high of $68.85. The company has a market capitalization of $12.20 million, a price-to-earnings ratio of -0.81 and a beta of 4.87. The firm’s 50-day moving average is $15.23 and its 200 day moving average is $7.33.

Astrotech (NASDAQ:ASTC – Get Free Report) last announced its earnings results on Wednesday, May 13th. The aerospace company reported ($2.25) earnings per share (EPS) for the quarter. The business had revenue of $0.34 million for the quarter. Astrotech had a negative net margin of 1,397.82% and a negative return on equity of 81.85%.

Institutional Trading of Astrotech

A number of large investors have recently modified their holdings of the company. Susquehanna International Group LLP purchased a new position in Astrotech during the 3rd quarter worth $66,000. DRW Securities LLC lifted its holdings in shares of Astrotech by 168.5% in the 4th quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock worth $109,000 after buying an additional 19,747 shares during the period. Finally, J. Safra Sarasin Holding AG purchased a new stake in shares of Astrotech in the 1st quarter worth $140,000. Hedge funds and other institutional investors own 24.35% of the company’s stock.

About Astrotech

(Get Free Report)

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.

Further Reading